A Chinese infant with CACNA1C p.C1021R variant expands clinical phenotype of CACNA1C-related disorder
Congshan Jiang1, Yafei Zhou1, Siyu Zhang1
1Shaanxi Institute for Pediatric Diseases, Key Laboratory of Precision Medicine to Pediatric Diseases of Shaanxi Province, Xi'an Children's Hospital, Affiliated Children's Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710003, China.
Insights
CACNA1C-related disorder (CRD) is a rare genetic condition. This study expands its known symptoms to include cerebral infarction and combined T-cell and B-cell immunodeficiency, improving diagnosis and management.
Area of Science:
- Genetics
- Molecular Biology
- Clinical Medicine
Background:
- CACNA1C-related disorder (CRD) is a severe, rare multisystem disorder.
- Diagnostic and management challenges arise from CRD's rarity and variable expressivity.
- The NM_001129830.1: c.3061T>C (p.Cys1021Arg) variant in the CACNA1C gene is associated with Timothy syndrome (TS) features.
Abstract:
CACNA1C-related disorder (CRD), a severe multisystem disorder caused by variants of CACNA1C gene, presents significant diagnostic and management challenges due to its rarity and variable expressivity. This study leverages a detailed longitudinal case report and comprehensive literature review to expand the phenotypic spectrum of CRD with Timothy syndrome (TS) features associated with the CACNA1C NM_001129830.1: c.3061 T > C (p.Cys1021Arg) variant. We describe an individual with CRD exhibiting a severe multisystem phenotype including classic features like syndactyly, profound neurological symptoms, and cardiac arrhythmias. Critically, our detailed clinical and genetic analysis identified previously undocumented features for this specific variant: cerebral infarction, as well as a combined T-cell and B-cell immunodeficiency characterized by specific lymphocyte dysregulation. These novel findings necessitate refined diagnostic protocols and tailored management strategies. By redefining CRD with TS features as a profoundly multisystem disorder, this expanded understanding facilitates improved prognostication, genetic counseling, and targeted therapeutic interventions, aiming to transform management from unpredictable complications into predictable, preventable components, ultimately enhancing quality of life and survival.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pleiotropy
Cardiomyopathy III: Hypertrophic Cardiomyopathy


